Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission following second-line salvage therapy.
Medically reviewed by Khadeja Haye, MD The human papillomavirus (HPV) vaccine is recommended for people ages 9 to 26. Most ...